tiprankstipranks
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market
Holding AVBP?
Track your performance easily

ArriVent BioPharma, Inc. (AVBP) Financial Statements

22 Followers

ArriVent BioPharma, Inc. Financial Overview

ArriVent BioPharma, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.415; its P/E ratio is -11.35; ArriVent BioPharma, Inc. is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.80. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Sep 23Dec 22
Income Statement-
Total Revenue----
Gross Profit----
EBIT$ -20.56M$ -21.87M--
EBITDA$ -20.56M$ -21.87M--
Net Income Common Stockholders$ -20.56M$ -21.87M--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 282.86M$ 298.67M$ 166.36M$ 163.37M
Total Assets$ 292.71M$ 308.86M$ 181.99M$ 182.83M
Total Debt$ 213.00K$ 250.00K$ 44.00K$ 139.00K
Net Debt$ -282.64M$ -298.42M$ -166.31M$ -163.23M
Total Liabilities$ 15.22M$ 12.20M$ 10.10M$ 8.37M
Stockholders Equity$ 277.49M$ 296.66M$ 171.89M$ 174.46M
Cash Flow-
Free Cash Flow$ -16.34M$ -19.09M--
Operating Cash Flow$ -16.34M$ -19.09M--
Investing Cash Flow----
Financing Cash Flow$ 531.00K$ 363.00K--
Currency in USD

ArriVent BioPharma, Inc. Earnings and Revenue History

ArriVent BioPharma, Inc. Debt to Assets

ArriVent BioPharma, Inc. Cash Flow

ArriVent BioPharma, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis